← Leaderboards
Lawrence S Lamb
Palmetto Health Richland
$1,679,399
Attributed
$2,249,059
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $400.6K · FY2006–19$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$2,423,661 · 11
By mechanism
P50$1,267,694 · 2
R21$806,763 · 3
S10$349,204 · 6
Top collaborators
- Brigitte M Ronnett5 shared
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsCellsBaseDesignProgramsResearch PersonnelBiologicalBloodLaboratoriesLiquid SubstanceLaser Capture MicrodissectionMalignant Neoplasm Of Cervix UteriColoradoLesionHuman TissueDatabasesImmunologyFundingAlabamaHistologicBiometryEnrollmentData ManagementEnsure
Grant awards (19)
Tissue and Pathology/Immunology Core$128,374
P50 · FY2019 · CA · contact PI
Tissue/Pathology Core$227,591
P50 · FY2013 · CA
Tissue/Pathology Core$232,653
P50 · FY2012 · CA
Tissue/Pathology Core$230,142
P50 · FY2011 · CA
Tissue/Pathology Core$217,451
P50 · FY2010 · CA
Donor Innate Lymphocyte Infusion Product for Immunotherapy of Glioblastoma Multif$183,125
R21 · FY2010 · NS · contact PI
Tissue/Pathology Core$231,483
P50 · FY2009 · CA
Feasibility of gamma/delta T cell immunotherapy for glioblastoma$71,200
R21 · FY2009 · NS · contact PI
Feasibility of gamma/delta T cell immunotherapy for glioblastoma$158,594
R21 · FY2008 · NS · contact PI
Feasibility of gamma/delta T cell immunotherapy for glioblastoma$158,594
R21 · FY2007 · NS · contact PI
BD Biosciences FACS Canto Flow Cytometer$174,602
S10 · FY2006 · RR · contact PI
BD BIOSCIENCES FACS CANTO FLOW CYTOMETER: AIDS$52,381
S10 · FY2006 · RR · contact PI
BD BIOSCIENCES FACS CANTO FLOW CYTOMETER; IMMUNOLOGY, CELL BIOLOGY$52,381
S10 · FY2006 · RR · contact PI
BD BIOSCIENCES FACS CANTO FLOW CYTOMETER: CANCER: MELANOMA, GLIOMA$34,920
S10 · FY2006 · RR · contact PI
BD BIOSCIENCES FACS CANTO FLOW CYTOMETER: SICKLE CELL DISEASE, GENE THERAPY$17,460
S10 · FY2006 · RR · contact PI
BD BIOSCIENCES FACS CANTO FLOW CYTOMETER: MOUSE STEM CELLS: ADULT & EMBRYONIC$17,460
S10 · FY2006 · RR · contact PI
ANTILEUKEMIC EFFECT OF GAMMA/DELTA T CELLS$109,352
R21 · FY2001 · CA
ANTILEUKEMIC EFFECT OF GAMMA/DELTA T CELLS$20,230
R21 · FY2001 · CA
ANTILEUKEMIC EFFECT OF GAMMA/DELTA T CELLS$105,668
R21 · FY2000 · CA